Fabry disease
Sanofi Genzyme, PerkinElmer Launch Free Dx Program for Patients With Lysosomal Storage Disorders
The Lantern Project will screen for patients who may be suffering from Gaucher disease, Fabry disease, Pompe disease, MPS I, or ASMD, and offer confirmatory DNA testing.
The program marks a expansion of Rosetta Green's focus, which has primarily been on improving crop traits and algae for biofuel production.